Q07817 |
B2CL1_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
Q07817 |
B2CL1_HUMAN |
Myeloproliferative neoplasm [ICD-11: 2A20] |
Q07817 |
B2CL1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q07817 |
B2CL1_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q07817 |
B2CL1_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
Q07817 |
B2CL1_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
Q07817 |
B2CL1_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
Q07817 |
B2CL1_HUMAN |
Myeloproliferative neoplasm [ICD-11: 2A20] |
Q07817 |
B2CL1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q07817 |
B2CL1_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q07817 |
B2CL1_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
Q07817 |
B2CL1_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
Q07820 |
MCL1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q07820 |
MCL1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
Q07820 |
MCL1_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
Q07820 |
MCL1_HUMAN |
Mature B-cell lymphoma [ICD-11: 2A85] |
Q07820 |
MCL1_HUMAN |
Melanoma [ICD-11: 2C30] |
Q07820 |
MCL1_HUMAN |
Multiple myeloma [ICD-11: 2A83] |
Q07820 |
MCL1_HUMAN |
Trematode disease [ICD-11: 1F8Y] |
Q07820 |
MCL1_HUMAN |
Asthma [ICD-11: CA23] |
Q07820 |
MCL1_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
Q07820 |
MCL1_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q07820 |
MCL1_HUMAN |
Malignant intestine neoplasm [ICD-11: 2C0Z] |
Q07820 |
MCL1_HUMAN |
Mastocytosis [ICD-11: 2A21] |
Q07820 |
MCL1_HUMAN |
Mature B-cell lymphoma [ICD-11: 2A85] |
Q07820 |
MCL1_HUMAN |
Myeloproliferative neoplasm [ICD-11: 2A20] |
P10415 |
BCL2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P10415 |
BCL2_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P10415 |
BCL2_HUMAN |
Motor neuron disease [ICD-11: 8B60] |
P10415 |
BCL2_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P10415 |
BCL2_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P10415 |
BCL2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10415 |
BCL2_HUMAN |
Stomach cancer [ICD-11: 2B72] |
P10415 |
BCL2_HUMAN |
Melanoma [ICD-11: 2C30] |
P10415 |
BCL2_HUMAN |
Multiple myeloma [ICD-11: 2A83] |
P10415 |
BCL2_HUMAN |
Myeloproliferative neoplasm [ICD-11: 2A20] |
P10415 |
BCL2_HUMAN |
Ovarian dysfunction [ICD-11: 5A80] |
P10415 |
BCL2_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P10415 |
BCL2_HUMAN |
Lung cancer [ICD-11: 2C25] |
P10415 |
BCL2_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P10415 |
BCL2_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10415 |
BCL2_HUMAN |
Chronic myelomonocytic leukaemia [ICD-11: 2A40] |
P10415 |
BCL2_HUMAN |
Follicular lymphoma [ICD-11: 2A80] |
P10415 |
BCL2_HUMAN |
Mature B-cell lymphoma [ICD-11: 2A85] |
P10415 |
BCL2_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P10415 |
BCL2_HUMAN |
Psoriasis [ICD-11: EA90] |
P10415 |
BCL2_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P10415 |
BCL2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10415 |
BCL2_HUMAN |
Leukaemia [ICD-11: 2A60-2B33] |
P10415 |
BCL2_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P10415 |
BCL2_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10415 |
BCL2_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P10415 |
BCL2_HUMAN |
Lung cancer [ICD-11: 2C25] |
P10415 |
BCL2_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P10415 |
BCL2_HUMAN |
Melanoma [ICD-11: 2C30] |
P10415 |
BCL2_HUMAN |
Multiple myeloma [ICD-11: 2A83] |